Trial intelligence / Profile preview

Testosterone and Metabolites in FtM Transsexuals

NCT00146146Phase 3Completed

Sponsor
Unità Operativa Complessa di Ostetricia e Ginecologia
Start
May 2005
Primary completion
May 2006
Modality
Hormone, Biologic
Countries
1
01

Overview

Phase 3, randomised, open-label trial of testosterone undecanoate in gender dysphoria (GD), sponsored by Unità Operativa Complessa di Ostetricia e Ginecologia. Started May 2005; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on NCT00146146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00146146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call